Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Elisabetta PatornoPhyo Than HtooRobert J GlynnSebastian G SchneeweissDeborah J WexlerAjinkya PawarLily G BessetteKristyn ChinBrendan M EverettSeoyoung C KimPublished in: Annals of internal medicine (2021)
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School.
Keyphrases
- cardiovascular disease
- healthcare
- polycystic ovary syndrome
- palliative care
- clinical practice
- quality improvement
- type diabetes
- breast cancer risk
- pregnancy outcomes
- tertiary care
- pain management
- adverse drug
- cervical cancer screening
- affordable care act
- emergency department
- cardiovascular risk factors
- metabolic syndrome
- skeletal muscle
- health insurance
- chronic pain
- drug induced